Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23908226 | 0.96 | TSHR (0.50) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL10022793 | 0.83 | MAPT (0.44) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL12895124 | 0.81 | PGK1 (0.45) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL21259132 | 0.79 | EGFR (0.55) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL3373620 | 0.79 | MAPT (0.44) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL9172810 | 0.79 | TSHR (0.43) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL12892630 | 0.79 | TAAR1 (0.49) | TSHREGFRMAPTHTTCCNT1 | |
| SCHEMBL702504 | 0.78 | NPSR1 (0.47) | TSHREGFRMAPTPPARDPOLB | |
| SCHEMBL6298899 | 0.78 | EGFR (0.43) | TSHREGFRMAPTHTTPPARD | |
| SCHEMBL3042909 | 0.78 | TAAR1 (0.43) | TSHREGFRMAPTHTTPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6875895-B2 | Such as 1,4-bis(2-(4-bromophenyl)-2-phenylethenyl)-2-(2-ethylhexyloxy)-5 -methoxybenzene; for polymerization into a light-emitting material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-04-05 | — | — | US | disclosed |
| US-20030100786-A1 | Bis (diphenylvinyl) arene compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100786-A1 | Bis (diphenylvinyl) arene compound | CBR1, AR, CYP1B1 | TSHR 3148/4885EGFR 928/4885MAPT 2710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.